Michael Duruisseaux
@MDuruisseaux
Thoracic Oncologist/Early Phase @CHUdeLyon
Deputy Director @CHUdeLyon Cancer Institute
Board Member @IFCTlung
President 🇨🇵 Cooperative Oncology Group Network
ID:1353586595602051072
25-01-2021 06:13:12
1,5K Tweets
689 Followers
92 Following
⭐️Oligonucleotide therapeutics are emerging as a powerful platform for modulating gene expression across a range of diseases and applications.
Science Magazine scim.ag/6DR
Dans cette étude thérapie onco orale non utilisée peut être réattribuée sous condition de bonne conservation Economie (680-1591$/participant) et limitation des déchets (-68%) #Transition ADEME Laurent Greillier Yann Nguyen
jamanetwork.com/journals/jamao…
#openaccess ESMO - Eur. Oncology ESMO Open genomic profiling in the management of #patients w rare #cancers :
Rare cancer patients show favourable response to matched therapies, with a higher ORR in early treatment lines.
#PrecisionMedicine OncoAlert 🚨
esmoopen.com/article/S2059-…
'Les non-fumeurs sont souvent l'objet de tabagisme passif, il faut absolument qu'on progresse sur les lieux de santé sans tabac, sur l'interdiction de fumer dans les lieux publics' : le Pr Marie Wislez est l'invitée de Géraldine Mayr #FranceBleu et Anne Orenstein dans #BonjourDocteur
Local T cell neighbourhoods determine outcome in non-small cell lung cancer treatment with KRAS-G12C inhibitors.
Timely and relevant work from Megan Cole and Panayiotis Anastasiou from the @JulianDownwardlab, and Claudia Lee from the Swanton Lab.
doi.org/10.1101/2024.0…
Just published in eBioMedicine – The Lancet Discovery Science!
Ever wondered why some heavy smokers never develop lung cancer, even in old age, while others do at a young age?
thelancet.com/journals/ebiom…
These clinically relevant phenotypes likely model extreme sensitivity and resistance to tobacco's
Yes, CA-125 #KELIM is now calculated in > 101 countries in the world , representing >50% countries on the globe 🌎🌍🌏… with about 3600 /month on biomarker-kinetic.org for #ovarian cancer management … Arcagy-Gineco HCL - Hospices Civils de Lyon World Ovarian Cancer Day & WOCCoalition Ovarian Cancer Canada Salvovar
Cliniciens, chercheurs, directeurs, cadres, personnels de recherche et des soins, partenaires industriels, ne manquez pas la première journée sur la pneumologie aux HCL le 11 juin prochain à la médiathèque santé HCL - Hospices Civils de Lyon Sébastien Couraud 🫁🚭🌍 Université Lyon 1 Michael Duruisseaux
Practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management - Michael Duruisseaux
oncodaily.com/47624.html
#oncodaily #oncology #cancer #LungCancerJournal #Sotorasib #AdverseEvents #Hepatotoxicity #MedicalGuidance #FrenchExpertise #MedicalResearch